Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a microscope lens in flat design.

May 27, 2026

NIT Rourkela Develops AI-Enabled Autofocusing Technology for Microscopic Imaging

Researchers at NIT Rourkela have unveiled an innovative AI-enabled autofocusing technology aimed at enhancing microscopic imaging for biomedical diagnostics. This development, in partnership with Glowvista Instruments, addresses key challenges faced by traditional microscopy systems, such as manual focus adjustments that can lead to diagnostic inaccuracies and delays.The newly patented technology, titled “A Method for Autofocusing in Optofluidic Microsystems and Processes,” integrates deep learn
An MRI machine in a dimly lit hospital imaging room with a patient on the table.

May 27, 2026

Diagnostic Imaging Market Expected to Reach US$68.81 Billion by 2034 as AI-Powered Technologies Transform Healthcare Diagnostics

The diagnostic imaging market is on track to reach approximately US$68.81 billion by 2034, driven by advancements in AI and increasing healthcare demands.As chronic illnesses rise and the emphasis on preventive care intensifies, diagnostic imaging has become crucial in clinical decision-making. Various imaging technologies, such as X-rays, MRIs, and CT scans, enable healthcare professionals to accurately visualize internal structures, facilitating early disease detection and better patient outco
A minimalist representation of a brain and neurons for Alzheimer's research.

May 27, 2026

Alzheimer’s AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus – More Stocks Inside

IGC Pharma, Inc. is drawing attention in the biotech sector as it progresses with its AI-driven Alzheimer’s therapies, particularly through the ongoing Phase 2 CALMA clinical trial for its candidate IGC-AD1. The trial has reached about 80% patient enrollment, nearing its goal of 146 participants.The company is expanding its clinical trial network with new sites in New York and leveraging a national clinical network to enhance enrollment efforts. IGC Pharma is committed to integrating AI technolo
A test tube in a life sciences lab

May 27, 2026

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals is set to establish a Global Capability Centre (GCC) in Hyderabad, aiming to enhance its operations and support its mission of delivering new medicines to patients.This strategic move will allow Regeneron to expand its global footprint and create hundreds of jobs over the coming years. The company, recognized for its innovative approach in biotechnology, currently has 15 approved medicines and a robust pipeline of nearly 50 candidates across various therapeutic areas.Hy
A close-up of a cancer tissue sample viewed through a microscope in a laboratory setting.

May 27, 2026

Tempus AI’s Record ASCO Showing Tests Cancer Data And Revenue Story

Tempus AI made a significant impact at the 2026 ASCO Annual Meeting with 37 accepted abstracts, marking its largest presence at the event to date.The focus of the research is on Tempus AI's multimodal data platform and its applications in cancer care, reflecting a growing interest from the oncology community. This level of engagement suggests that Tempus AI’s technology is becoming increasingly integrated into real-world oncology studies, which is crucial for the advancement of precision medicin
Minimalist illustration of a stock chart and dollar sign representing biotech investment

May 27, 2026

RF Acquisition II Shares Steady as $1.5 Billion AI-Biotech SPAC Deal Draws Attention Again

RF Acquisition Corp II (RFAI) is navigating a critical phase as it seeks to finalize its merger with Nanyang Biologics, a deal valued at approximately $1.5 billion. Despite the potential of this AI-driven biotech partnership, investor sentiment remains cautious, as reflected in the stock's stagnant trading price.On May 26, RFAI shares traded at $10.97, closely aligning with the redemption value of $10.95. The SPAC's activity has been minimal, with only 39 shares changing hands, indicating a lack
Scales of justice balanced with an AI brain silhouette

May 26, 2026

Legal hiring in 2026: AI skills and strategic expertise top employer demand

The legal hiring landscape is evolving rapidly as artificial intelligence becomes a crucial skill for legal professionals. A recent report from Major, Lindsey & Africa highlights that employers across the U.S. are increasingly seeking lawyers who can integrate legal knowledge with AI proficiency, strategic acumen, and cross-functional leadership.As legal departments adapt to changing demands, sectors such as private equity, healthcare, and technology are seeing heightened demand for candidates w
A swab test kit on a lab table in a dimly lit clinical setting.

May 26, 2026

Light AI’s Digital Clinical Lab Targets Rapid Strep Diagnostics

Light AI is poised to revolutionize rapid strep diagnostics through its innovative Digital Clinical Lab, which utilizes smartphone technology for quick testing. This advancement could significantly enhance patient care by allowing clinicians to triage patients in mere minutes instead of days.The burden of Group A Streptococcus infections is substantial, affecting around 600 million individuals annually, particularly children. Current diagnostic methods often require trained personnel and resourc
Minimalist illustration of a cell and gene therapy concept

May 26, 2026

Europe Pharmaceutical CDMO Market Forecast to Hit USD 94.94 Billion by 2035 as Biologics, AI-Powered Manufacturing, and Advanced Therapies Redefine Drug Outsourcing

The European Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is poised for significant growth, projected to reach approximately USD 94.94 billion by 2035, up from USD 49.06 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.59% during this period.This expansion is largely driven by the increasing demand for personalized therapies, particularly in the realm of cell and gene therapies, alongside the complexities of biologics development. The mark
Minimalist illustration of a stock chart with an upward arrow

May 26, 2026

A Look At Quest Diagnostics (DGX) Valuation After Strong Q1 Beat And Raised Full Year Guidance

Quest Diagnostics has recently gained attention following a robust first quarter, surpassing revenue and earnings expectations while also raising its full-year guidance.The company has seen a positive trend in its stock performance, with a 2.53% increase over the past week and a 12.33% rise year-to-date. Over the past year, shareholders have enjoyed a total return of 14.42%, alongside impressive returns of 54.80% and 69.14% over the last three and five years, respectively. This indicates a stron
A tissue sample under a microscope in a lab setting

May 26, 2026

Prezent Vivo and Nested Knowledge Partner to Bring AI-Powered Competitive Intelligence to Life Sciences Teams

Prezent Vivo and Nested Knowledge have formed a strategic partnership aimed at enhancing competitive intelligence for life sciences teams. By integrating Prezent Vivo's AI-driven communication capabilities with Nested Knowledge's evidence synthesis technology, the collaboration seeks to streamline the preparation process for medical congresses and ongoing competitive analysis.The partnership leverages Prezent Vivo's model that combines artificial intelligence with human expertise, enabling rapid
A minimalist illustration of a microscope with a lens in a dark color scheme.

May 26, 2026

NIT Rourkela Develops AI-Enabled Microscopy For Next-Generation Healthcare Diagnostics

Researchers at NIT Rourkela have developed an innovative AI-enabled microscopy technology aimed at enhancing biomedical diagnostics.This new autofocusing technology, patented under the title ‘A Method for Autofocusing in Optofluidic Microsystems and Processes,’ is designed to address the limitations of conventional microscopy systems, which often rely on manual adjustments that can introduce errors and delays in diagnosis. The team, led by Prof. Earu Banoth and collaborating with Glowvista Instr